Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 14, 2002Clinical Science

Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does intra-arterial BQ-123 alter forearm blood flow in response to ET-1 and noradrenaline in young normotensive subjects?

Population

n=6 young normotensive subjects, age 25-34 years

Comparison

Intra-arterial infusion of BQ-123 vs Intra-arterial infusion of sodium nitroprusside…

Design

RCT, randomized, double-blind

Follow-up

acute (during 60 min infusion)

Authors

RWR. WimalasunderaUniversity College HospitalSTSimon ThomPreventive CardiologyLRL. ReganUniversity of London

Discussion

Loading...

Member takes

Implication

ET_A blockade with BQ-123 spares basal tone yet abolishes ET-1 vasoconstriction in normotensives; confirms selective antagonism for targeted vascular research.

Structured PICO

Does intra-arterial BQ-123 alter forearm blood flow in response to ET-1 and noradrenaline in young normotensive subjects?

P
Population
n=6 young normotensive subjects, age 25-34 years
I
Intervention
Intra-arterial infusion of BQ-123 (50 nmol/min for 60 min, or 300 nmol/min for 5 min followed by saline for 55 min)
C
Comparator
Intra-arterial infusion of sodium nitroprusside (SNP; 12 nmol/min for 60 min) or saline
O
Outcome
Changes in forearm blood flow (FBF) in response to ET-1 and noradrenaline, measured by forearm occlusion plethysmographysurrogate

BQ-123 acts as a selective ET-1 antagonist but does not appear to significantly influence resting forearm vascular tone in young normotensive subjects.

Cite This Study

Wimalasundera et al. (2002) studied this question.

synapsesocial.com/papers/6a82f4bd28b8a62be998f808https://doi.org/10.1042/cs1020661
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Systemic and renal effects of an ET<sub>A</sub> receptor subtype‐specific antagonist in healthy subjects1998 · 46 citations
  2. 2BQ-123, a selective endothelin subtype A-receptor antagonist, lowers blood pressure in different rat models of hypertension1994 · 47 citations
  3. 3Systemic Endothelin Receptor Blockade Decreases Peripheral Vascular Resistance and Blood Pressure in Humans1996 · 322 citations
  4. 4<i>In vivo</i> pharmacological characterization of the non‐peptide endothelin receptor antagonist SB 2096701995 · 18 citations
  5. 5<i>In‐vivo</i>effects of endothelin‐1 and ET<sub>a</sub>receptor blockade on arterial, venous and capillary functions in skeletal muscle1993 · 24 citations